We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection) is now available in the United States. Victoza is...
Second Consecutive Year for Diabetes Care Leader PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company focusing on diabetes care, has been named to FORTUNE...
- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 14 /PRNewswire/ -- A new analysis found that the cost of diabetes and pre-diabetes...
We are advised by National Changing Diabetes Program that journalists and other readers should disregard the news release, Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007...
- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 13 /PRNewswire/ -- A new analysis found that the cost of diabetes and pre-diabetes...
Study Shows Relief of Postmenopausal Symptoms PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose...
Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the United States will almost double over the next 25...
Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the United States will almost double over the next 25...
Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Nearly one-third of doctors surveyed said they...
Expanded Web Site and Facebook Wall Provide Resources to Hemophilia with Inhibitors Community PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced the re-launch of its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.002 | -2.08333333333 | 0.096 | 0.098 | 0.092 | 155012 | 0.09550653 | DE |
4 | 0.003 | 3.2967032967 | 0.091 | 0.14 | 0.081 | 293811 | 0.09863482 | DE |
12 | 0.006 | 6.81818181818 | 0.088 | 0.14 | 0.081 | 175329 | 0.09935355 | DE |
26 | -0.036 | -27.6923076923 | 0.13 | 0.14 | 0.081 | 161466 | 0.10127824 | DE |
52 | -0.081 | -46.2857142857 | 0.175 | 0.245 | 0.081 | 139975 | 0.1315954 | DE |
156 | -0.126 | -57.2727272727 | 0.22 | 0.275 | 0.081 | 171273 | 0.16286241 | DE |
260 | 0.079 | 526.666666667 | 0.015 | 0.275 | 0.005 | 1376756 | 0.0219659 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions